JPS6490132A - Superoxide dismutase derivative - Google Patents

Superoxide dismutase derivative

Info

Publication number
JPS6490132A
JPS6490132A JP62248476A JP24847687A JPS6490132A JP S6490132 A JPS6490132 A JP S6490132A JP 62248476 A JP62248476 A JP 62248476A JP 24847687 A JP24847687 A JP 24847687A JP S6490132 A JPS6490132 A JP S6490132A
Authority
JP
Japan
Prior art keywords
rhizome
extract
superoxide dismutase
senkyu
toki
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP62248476A
Other languages
Japanese (ja)
Inventor
Kazuhiro Yoshino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Priority to JP62248476A priority Critical patent/JPS6490132A/en
Publication of JPS6490132A publication Critical patent/JPS6490132A/en
Pending legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE:To provide a superoxide dismutase derivative containing an organic solvent extract of SENKYU (rhizome of Cnidium officinale) or TOKI (rhizome of Angelica acutiloba) and widely utilizable as a remedy or preventive for inflammation, ischemic diseases, aging, senile diseases, etc. CONSTITUTION:Rhizome, especially dried rhizome of SENKYU or TOKI is extracted with 1-20 times weight of an organic solvent at room temperature or under heating (30-70 deg.C) and the obtained extract is used as an active component. The amount of the extract is 0.001-10% when used in the form of an external drug to be applied to the skin, etc., and is 5mg-5g/kg-body weight in the case of using as a peroral drug or injection.
JP62248476A 1987-10-01 1987-10-01 Superoxide dismutase derivative Pending JPS6490132A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62248476A JPS6490132A (en) 1987-10-01 1987-10-01 Superoxide dismutase derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62248476A JPS6490132A (en) 1987-10-01 1987-10-01 Superoxide dismutase derivative

Publications (1)

Publication Number Publication Date
JPS6490132A true JPS6490132A (en) 1989-04-06

Family

ID=17178715

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62248476A Pending JPS6490132A (en) 1987-10-01 1987-10-01 Superoxide dismutase derivative

Country Status (1)

Country Link
JP (1) JPS6490132A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002541194A (en) * 1999-04-13 2002-12-03 サイジェニック カンパニー リミテッド A composition for preventing and treating dementia comprising a hydroxycinnamic acid derivative or a touki extract containing the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002541194A (en) * 1999-04-13 2002-12-03 サイジェニック カンパニー リミテッド A composition for preventing and treating dementia comprising a hydroxycinnamic acid derivative or a touki extract containing the same

Similar Documents

Publication Publication Date Title
DE3679722D1 (en) SPRAYABLE PHARMACEUTICAL PREPARATION FOR TOPICAL APPLICATION.
ATE311178T1 (en) PHARMACEUTICAL FORMULATIONS WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS
NO162103C (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION
NO178914C (en) Process for the preparation of a pharmaceutical composition for the treatment of Diabetes mellitus
ES2045194T3 (en) A PROCEDURE FOR OBTAINING COMPRESSED AND MOLDED PHARMACEUTICAL PREPARATIONS.
DE3872739D1 (en) SLOW RELEASE MEDICINAL PRODUCTS.
HUP9602498A2 (en) Pharmaceutical compositions of antimicrobial activity
KR970009581B1 (en) Composition for topical use containing depolymerized deoxyribonucleic acids in the skin and body cosmetic treathent
ES2063296T3 (en) PROCEDURE FOR MANUFACTURING TABLETS CONTAINING NAPROXENO OR NAPROXENO SODICO DRIED BY SPRAY.
JPS6490132A (en) Superoxide dismutase derivative
JPS565465A (en) Benzimidazole derivative* its manufacture and medicinal composition of same as active component
GB2021409A (en) Pharmaceutical composition
KR870007699A (en) Ready-to-use compositions in the form of preparations typically used in medicinal and cosmetic applications
CA2276676A1 (en) Therapeutic agent for treating ulcerative colitis
DK0694306T3 (en) Antiviral powder, antiviral extract and pharmaceutical composition containing said powder and / or said extract
DE59101818D1 (en) Pharmaceutical preparation containing stigmasta-4-en-3-one and their use.
JPS5562005A (en) Skin cosmetic
DE68906205D1 (en) COSMETIC AND PARAMEDICAL PREPARATIONS.
AR227020A1 (en) HERBICIDE COMPOSITION CONTAINING AS AN ACTIVE AGENT DERIVATIVES OF 3,5-DIOXO-1,2,4-TRIAZINE; DERIVATIVES OF 3,5-DIOXO-1,2,4-TRIAZINE OF EXCLUSIVE APPLICATION IN SUCH COMPOSITIONS AND PROCEDURE FOR PREPARING SUCH DERIVATIVES
JPS57167909A (en) Cosmetic
JPS6483024A (en) Cataplasm for cold
KR910000144A (en) Pigmentation cure
GB2031410B (en) Derivatives of 1,3 benzoxazine 2,4 dione,their preparation and their application as medicants
ES2033512T3 (en) ANTI-ASTHENIC COMPOSITION, ITS PREPARATION PROCEDURE AND ITS USE.
NO158186C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CIS-2- (1H-IMIDAZOLYLMETHYL) -3-DIFLUOROBENZYLOXY-2,3-DIHYDROFLUORBENZO (B) THIOPHENER.